In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Orr

Managing Editor, Policy & Regulation

Washington, DC

Elizabeth leads a small team of Medtech Insight reporters devoted to covering medical device and diagnostics regulation in the US and abroad. As a reporter, she focuses on FDA regulation, legislation, and legal issues. A graduate of the University of Maryland College Park, she worked for outlets including FDA News, DecisionHealth (formerly UCG) and the Washington Examiner before joining Pharma Intelligence in 2015. She lives in Arlington, VA, with her husband and children.

Latest From Elizabeth Orr

Minute Insight: Thermo Fisher Gets FDA OK On Cancer Companion Diagnostic

The US FDA has approved additional indications for Thermo Fisher Scientific’s Oncomine Dx Target, allowing the companion diagnostic to be used to detect more varieties of lung and thyroid cancer.

Minute Insights Personalized Medicine

Deal Reached On FDA User Fee Renewal

Committee leaders in the US Congress have agreed on a stripped-down path to user fee reauthorization, which will not include FDA oversight of diagnostic tests.

Policy User Fees

OIG: FDA’s EUA Approach Allowed Bad Tests To Reach Market

A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.

Coronavirus COVID-19 Regulation

US FDA Finalizes Medical Device Electronic Submissions Guidance

The guidance document explains the history of and requirements for electronic submissions of 510(k)s. 

OTC Devices Guidance Documents

FDA Finalizes Electronic Submissions Guidance

The guidance document explains the history of and requirements for electronic submissions of 510(k)s. 

Regulation Guidance Documents

Teamwork: FDA And NIH Join Forces To Fund Neurodegenerative Disease Research, Medical Device Development Tools

The two federal agencies are working together to research rare conditions and fund grants for small businesses creating medical device development tools.

Policy FDA
See All
UsernamePublicRestriction

Register